- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Discovery Laboratories Inc+ Add to Watchlist
DSCO:US0.8195 USD 0.0006 0.07%
As of 12:57:16 ET on 05/28/2015.
Company Profile for Discovery Laboratories Inc (DSCO)
Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.
Discovery Laboratories Inc
Key Executives for Discovery Laboratories Inc (DSCO)
|John G CooperPresident/CEO||John A TattorySenior VP/CFO|
|Steven G SimonsonSenior VP/Chief Dev Ofcr||Mary B TempletonSenior VP/Secy/Gen Cnsl|
|Kathryn A ColeSenior VP:Human Resources||Lawrence WeinsteinVP:Medical Device Development|
|Thomas C HoyVP:Manufacturing Ops||Michael L MageeVP:Quality Operations|